US-based Elixir Medical has announced positive one-year results from the DESolve Nx international pivotal clinical trial for the CE Mark-approved, fully bioresorbable DESolve Novolimus eluting coronary scaffold system. At one year, the ...
Tags: Elixir Medical, NX Clinical Trial